These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21496467)

  • 21. Prevention of neonatal group B streptococcal infections: advances in maternal vaccine development.
    Coleman RT; Sherer DM; Maniscalco WM
    Obstet Gynecol; 1992 Aug; 80(2):301-9. PubMed ID: 1635750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo.
    Ebert T; Smith S; Pancari G; Clark D; Hampton R; Secore S; Towne V; Fan H; Wang XM; Wu X; Ernst R; Harvey BR; Finnefrock AC; Wang F; Tan C; Durr E; Cope L; Anderson A; An Z; McNeely T
    Hum Antibodies; 2010; 19(4):113-28. PubMed ID: 21178283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination With a Latch Peptide Provides Serotype-Independent Protection Against Group B Streptococcus Infection in Mice.
    Lin SM; Jang AY; Zhi Y; Gao S; Lim S; Lim JH; Song JY; Sullam PM; Rhee JH; Seo HS
    J Infect Dis; 2017 Dec; 217(1):93-102. PubMed ID: 29106586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recombinant fragments of conservative proteins of group B streptococci as a basis of specific vaccine].
    Suvorov AN; Grabovskaia KB; Leont'eva GF; Meringova LF; Koroleva IN; Duplik NV; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):44-50. PubMed ID: 20465000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies raised in animals against the Streptococcus agalactiae proteins c alpha and R4 and normal human serum antibodies target distinct epitopes.
    Moyo SR; Maeland JA
    J Med Microbiol; 2003 May; 52(Pt 5):379-383. PubMed ID: 12721312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus.
    Ricci ML; von Hunolstein C; Gomez MJ; Parisi L; Tissi L; Orefici G
    J Med Microbiol; 1996 Jun; 44(6):475-81. PubMed ID: 8636965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.
    Alves J; Madureira P; Baltazar MT; Barros L; Oliveira L; Dinis-Oliveira RJ; Andrade EB; Ribeiro A; Vieira LM; Trieu-Cuot P; Duarte JA; Carvalho F; Ferreira P
    PLoS One; 2015; 10(12):e0144196. PubMed ID: 26673420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrapulmonary bacterial clearance of type III group B streptococcus is reduced in preterm compared with term rabbits and occurs independent of antibody.
    Hall SL; Sherman MP
    Am Rev Respir Dis; 1992 May; 145(5):1172-7. PubMed ID: 1586063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface-localized protein antigens of group B streptococci.
    Ferrieri P
    Rev Infect Dis; 1988; 10 Suppl 2():S363-6. PubMed ID: 3055205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.
    Raff HV; Siscoe PJ; Wolff EA; Maloney G; Shuford W
    J Exp Med; 1988 Sep; 168(3):905-17. PubMed ID: 3049909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization.
    Dos Santos NFB; da Silva LR; Costa FJMD; de Mattos DM; de Carvalho E; Ferreira LCS; Ferreira RCC
    Vaccine; 2020 Jul; 38(33):5286-5296. PubMed ID: 32571719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse-protective antibodies against the Ibc proteins of group B streptococci.
    Bevanger L; Naess AI
    Acta Pathol Microbiol Immunol Scand B; 1985 Apr; 93(2):121-4. PubMed ID: 3893032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.
    Seepersaud R; Hanniffy SB; Mayne P; Sizer P; Le Page R; Wells JM
    Infect Immun; 2005 Mar; 73(3):1671-83. PubMed ID: 15731068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus.
    Shigeoka AO; Pincus SH; Rote NS; Hill HR
    J Infect Dis; 1984 Mar; 149(3):363-72. PubMed ID: 6371154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyvalent group B streptococcal immune globulin for intravenous administration: overview.
    Fischer GW; Hemming VG; Gloser HP; Bachmayer H; von Pilar CE; Wilson SR; Baron PA
    Rev Infect Dis; 1990; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB; Edwards MS; Baker CJ
    J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci.
    Hill HR; Gonzales LA; Knappe WA; Fischer GW; Kelsey DK; Raff HV
    J Infect Dis; 1991 Apr; 163(4):792-8. PubMed ID: 2010632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-independent protection in mice against type Ia group B streptococcus lethal infection.
    Scaringi L; Tissi L; Cornacchione P; Rosati E; Campanelli C; von Hunolstein C; Orefici G; Rossi R; Marconi P
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):151-62. PubMed ID: 7804166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic diversity in the alpha C protein of group B streptococci.
    Madoff LC; Hori S; Michel JL; Baker CJ; Kasper DL
    Infect Immun; 1991 Aug; 59(8):2638-44. PubMed ID: 1855984
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Pietrocola G; Arciola CR; Rindi S; Montanaro L; Speziale P
    Front Immunol; 2018; 9():602. PubMed ID: 29686667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.